The Board Members at Pieris Pharmaceuticals play a crucial role in providing strategic direction, governance, and oversight for the company's operations and research initiatives. They leverage their diverse expertise in biotechnology, finance, and corporate governance to guide the development of Anticalin-based drugs and ensure alignment with the company’s mission to innovate in addressing validated disease pathways. Additionally, they facilitate key decisions regarding funding, partnerships, and long-term growth strategies.
View all